Even though Advair’s main patent expired in 2010 and the patent on the Diskus inhaler expired in 2016, until now no-one has managed to get the FDA to approve a cheaper copy of the drug-device ...

Hikma's filing for a generic version of GlaxoSmithKline's Advair Diskus has been accepted by the ... performance in 2015 – a year that saw a 30% decrease in generics revenue compared to 2014.

The US Food and Drug Administration approved Hikma's Abbreviated New Drug Application (ANDA) for generic Advair Diskus in December 2020. However, the company has since submitted an amendment to ...

Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is ... twice daily from a Diskus™ inhaler for a 4-week ...